Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: Intranasal Ketalar vs Fentanyl for Pediatric Pain
NCT02778880Phase 3Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Mar 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of ketamine in pain and traumatic limb injury, sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Visual Analog Scale at 30 months. Started Mar 2016; status: completed.
02
Drugs
ketamine
03
Conditions
paintraumatic limb injury
Beyond the preview
Go deeper on NCT02778880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02778880.